QUIA — QUIA PHARMA AB (publ) Balance Sheet
0.000.00%
Last trade - 00:00
- SEK38.74m
- SEK36.16m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 4.55 | 8.59 | 5.34 | 2.57 | 0.101 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.679 | 0.728 | 0.833 | 0.748 | 0.681 |
Prepaid Expenses | |||||
Total Current Assets | 5.37 | 9.46 | 6.29 | 3.76 | 1.76 |
Net Property, Plant And Equipment | 0.527 | 0.937 | 0.778 | 0.524 | 0.27 |
Net Intangible Assets | |||||
Total Assets | 15.2 | 20.5 | 23.8 | 23.4 | 42 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10.2 | 19.3 | 6.72 | 5.82 | 26.7 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 23.8 | 20.5 | 23.7 | 21 | 26.7 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -8.57 | 0.07 | 0.023 | 2.41 | 15.3 |
Total Liabilities & Shareholders' Equity | 15.2 | 20.5 | 23.8 | 23.4 | 42 |
Total Common Shares Outstanding |